Newstral
Article
Forbes on 2022-12-23 16:27
BioNTech MRNA Vaccine Approved In Hong Kong, Week In Review
Related news
- BHong Kong Halts Use of BioNTech Vaccine Over Packaging Issuesbarrons.com
- Hong Kong halts use of BioNTech vaccine due to packagingCNN
- Hong Kong approves baby version of BioNTech vaccine for toddlersThe Jerusalem Post (JPost.com)
- BioNTech can provide Covid-19 vaccine targeting Omicron to Hong Kong as early as the third quarter of the year if approvedSouth China Morning Post
- Probe Finds No Safety Problems With BioNTech Vaccine Packaging After Hong Kong Halts ShotsForbes
- Hong Kong Suspends Use Of Pfizer-BioNTech Vaccine Due To Defective Bottle LidsForbes
- Coronavirus: Hong Kong advisory committee recommends booster jab for those fully inoculated with BioNTech vaccineSouth China Morning Post
- Coronavirus: 1 million new doses of BioNTech vaccine arrive in Hong KongSouth China Morning Post
- Hong Kong and Macao suspend BioNTech coronavirus vaccine rollout due to packaging defectCNN
- Coronavirus: Pfizer-BioNTech Covid-19 vaccine first to seek roll-out approval in Hong KongSouth China Morning Post
- Coronavirus: Hong Kong confirms 13 new cases; 300,000 Pfizer-BioNTech vaccine shots land in citySouth China Morning Post
- Coronavirus: Hong Kong nurse suspended after giving man 2 BioNTech vaccine jabs in same sittingSouth China Morning Post
- Covid-19: China’s Sinopharm mRNA vaccine approved for clinical trialsSouth China Morning Post
- China approved an mRNA Covid vaccine, its first.The New York Times
- Coronavirus: Hong Kong confirms 3 imported Covid-19 cases as expert assures residents BioNTech vaccine safe for childrenSouth China Morning Post
- BioNTech vaccine should be effective in protecting against certain Covid-19 strains, medical experts in Hong Kong saySouth China Morning Post
- Coronavirus vaccine: Hong Kong elderly first in line for second-generation BioNTech shots as city rolls out Omicron-specific jabsSouth China Morning Post
- Coronavirus: Hong Kong expecting two new cases, while BioNTech vaccine bookings resume after 12-day suspension over defectsSouth China Morning Post
- Coronavirus: Hong Kong health experts push to expand vaccine programme to include BioNTech jabs for those aged 12 to 15South China Morning Post
- Coronavirus Hong Kong: BioNTech vaccine recipients have antibody levels 10 times higher than those who opted for Sinovac, researchers findSouth China Morning Post